PHARMACOGENOMICS

药物基因组学是一份同行评审的期刊，由与这一快速发展领域密切相关的研究人员和决策者撰写评论和报告。主要的目标是为社会提供一项基本的资源，使他们能随时掌握这一令人兴奋的领域所有领域的最新发展。药物基因组学关注与制药行业和更广泛的临床社区最直接相关的方面，包括:新药物基因组计划的出现及其对研发和监管战略的影响;获取和利用基因组信息的新兴技术;综述基因分型和特定治疗领域的临床数据;开发新的诊断产品和策略。药物基因组学是评论和分析的主要来源，为您带来来自该领域的企业和学术意见领袖的最高质量的专家分析。

Pharmacogenomics is a peer-reviewed journal presenting reviews and reports by the researchers and decision-makers closely involved in this rapidly developing area. Key objectives are to provide the community with an essential resource for keeping abreast of the latest developments in all areas of this exciting field. Pharmacogenomics focuses on those aspects that have the most direct relevance to the pharmaceutical industry and wider clinical community, including: The emergence of new pharmacogenomic initiatives and their impact on R&D and regulatory strategies; Emerging technologies for accessing and exploiting genomic information; Reviews of genotyping and clinical data in particular therapeutic areas; Development of novel diagnostic products and strategies. Pharmacogenomics is the leading source of commentary and analysis, bringing you the highest quality expert analyses from corporate and academic opinion leaders in the field.